Opioid Victims Confront Purdue Pharma’s Sacklers in Bankruptcy Court

Victims of the opioid epidemic confronted the Sackler family members who own Purdue Pharma for the first time in bankruptcy court as the OxyContin maker nears a possible exit from chapter 11 that requires $6 billion in settlement payments from its owners.

The Wall Street Journal | Legal | Farmacia |

Leer noticia completa en el medio original
Spanish